Cell surface-associated compounds of probiotic lactobacilli sustain the strain-specificity dogma

Current Opinion in Microbiology

Volumn 16, Issue 3, 2013, Pages 262-269

  Bron, Peter A ^a,b,c   Tomita, Satoru ^a,b   Mercenier, Annick ^d   Kleerebezem, Michiel ^a,b,d  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b NIZO FOOD RESEARCH   (Netherlands)

^c KLUYVER CENTRE FOR GENOMICS OF INDUSTRIAL FERMENTATION   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; GLYCOSYLATED PROTEIN; LIGAND; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2;

BACTERIAL STRAIN; CELL SURFACE; HOST CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; PROTEIN GLYCOSYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84881559071     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.06.001     Document Type: Review

References (64)

1. Aziz Q., Dore J., Emmanuel A., Guarner F., Quigley E.M. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013, 25:4-15.
2. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
3. Fouhy F., Ross R.P., Fitzgerald G.F., Stanton C., Cotter P.D. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 2012, 3:203-220.
4. Gosalbes M.J., Llop S., Valles Y., Moya A., Ballester F., Francino M.P. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy 2013, 43:198-211.
5. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., Angenent L.T., Ley R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4578-4585.
6. Scholtens P.A., Oozeer R., Martin R., Amor K.B., Knol J. The early settlers: intestinal microbiology in early life. Annu Rev Food Sci Technol 2012, 3:425-447.
7. Rajilic-Stojanovic M., Heilig H.G., Tims S., Zoetendal E.G., de Vos W.M. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 2012, 9:2125-2136.
8. Tims S., Derom C., Jonkers D.M., Vlietinck R., Saris W.H., Kleerebezem M., de Vos W.M., Zoetendal E.G. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J 2012, 7:707-717.
9. Booijink C.C., El-Aidy S., Rajilic-Stojanovic M., Heilig H.G., Troost F.J., Smidt H., Kleerebezem M., De Vos W.M., Zoetendal E.G. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol 2010, 12:3213-3227.
10. Zoetendal E.G., Raes J., van den Bogert B., Arumugam M., Booijink C.C., Troost F.J., Bork P., Wels M., de Vos W.M., Kleerebezem M. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 2012, 6:1415-1426.
11. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
12. Jeffery I.B., Claesson M.J., O'Toole P.W., Shanahan F. Categorization of the gut microbiota: enterotypes or gradients?. Nat Rev Microbiol 2012, 10:591-592.
13. Whelan K., Quigley E.M. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013, (Epub ahead of print).
14. Bienenstock J., Gibson G.R., Klaenhammer T.R., Walker W.A., Neish A.S. New insights into probiotic mechanisms: a harvest from functional and metagenomic studies. Gut Microbes 2012, 4:94-100.
15. Bron P.A., van Baarlen P., Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 2012, 10:66-78.
16. Klaenhammer T.R., Kleerebezem M., Kopp M.V., Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol 2012, 12:728-734.
17. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 2010, 8:171-184.
18. Lee I.C., Tomita S., Kleerebezem M., Bron P.A. The quest for probiotic effector molecules-Unraveling strain specificity at the molecular level. Pharmacol Res 2012, 69:61-74.
19. Agustina R., Kok F.J., van de Rest O., Fahmida U., Firmansyah A., Lukito W., Feskens E.J., van den Heuvel E.G., Albers R., Bovee-Oudenhoven I.M. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 2012, 129:e1155-e1164.
20. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
21. Snel J., Vissers Y.M., Smit B.A., Jongen J.M., van der Meulen E.T., Zwijsen R., Ruinemans-Koerts J., Jansen A.P., Kleerebezem M., Savelkoul H.F. Strain-specific immunomodulatory effects of Lactobacillus plantarum strains on birch-pollen-allergic subjects out of season. Clin Exp Allergy 2011, 41:232-242.
22. Remus D.M., Kleerebezem M., Bron P.A. An intimate tete-a-tete-how probiotic lactobacilli communicate with the host. Eur J Pharmacol 2011, 668(Suppl. 1):S33-S42.
23. Wells J.M., Rossi O., Meijerink M., van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4607-4614.
24. Lebeer S., Claes I.J., Vanderleyden J. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol 2012, 20:5-10.
25. Kleerebezem M., Hols P., Bernard E., Rolain T., Zhou M., Siezen R.J., Bron P.A. The extracellular biology of the lactobacilli. FEMS Microbiol Rev 2010, 34:199-230.
26. Bron P.A., Tomita S., van Swam I.I., Remus D.M., Meijerink M., Wels M., Okada S., Wells J.M., Kleerebezem M. Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching. Microb Cell Fact 2012, 11:123.
27. Chapman C.M., Gibson G.R., Rowland I. Health benefits of probiotics: are mixtures more effective than single strains?. Eur J Nutr 2011, 50:1-17.
28. Meijerink M., Mercenier A., Wells J.M. Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials. Benef Microbes 2013, 4:83-100.
29. Volz T., Nega M., Buschmann J., Kaesler S., Guenova E., Peschel A., Rocken M., Gotz F., Biedermann T. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J 2010, 24:4089-4102.
30. Asong J., Wolfert M.A., Maiti K.K., Miller D., Boons G.J. Binding and cellular activation studies reveal that toll-like receptor 2 can differentially recognize peptidoglycan from gram-positive and gram-negative bacteria. J Biol Chem 2009, 284:8643-8653.
31. Dziarski R., Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun 2005, 73:5212-5216.
32. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004, 5:1000-1006.
33. Macho Fernandez E., Pot B., Grangette C. Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors?. Gut Microbes 2011, 2:280-286.
34. Macho Fernandez E., Valenti V., Rockel C., Hermann C., Pot B., Boneca I.G., Grangette C. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011, 60:1050-1059.
35. Bernard E., Rolain T., Courtin P., Guillot A., Langella P., Hols P., Chapot-Chartier M.P. Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan. J Biol Chem 2011, 286:23950-23958.
36. Vollmer W. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol Rev 2008, 32:287-306.
37. Claes I.J., Segers M.E., Verhoeven T.L., Dusselier M., Sels B.F., De Keersmaecker S.C., Vanderleyden J., Lebeer S. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact 2012, 11:161.
38. Jang K.S., Baik J.E., Han S.H., Chung D.K., Kim B.G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem Biophys Res Commun 2011, 407:823-830.
39. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 2005, 102:10321-10326.
40. Claes I.J., Lebeer S., Shen C., Verhoeven T.L., Dilissen E., De Hertogh G., Bullens D.M., Ceuppens J.L., Van Assche G., Vermeire S., et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol 2010, 162:306-314.
41. Mohamadzadeh M., Pfeiler E.A., Brown J.B., Zadeh M., Gramarossa M., Managlia E., Bere P., Sarraj B., Khan M.W., Pakanati K.C., et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4623-4630.
42. Khazaie K., Zadeh M., Khan M.W., Bere P., Gounari F., Dennis K., Blatner N.R., Owen J.L., Klaenhammer T.R., Mohamadzadeh M. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2012, 109:10462-10467.
43. Xia G., Kohler T., Peschel A. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol 2010, 300:148-154.
44. Tomita S., de Waard P., Bakx E.J., Schols H.A., Kleerebezem M., Bron P.A. The structure of an alternative wall teichoic acid produced by a Lactobacillus plantarum WCFS1 mutant contains a 1,5-linked poly(ribitol phosphate) backbone with 2-alpha-d-glucosyl substitutions. Carbohydr Res 2013, 370C:67-71.
45. Tomita S., Furihata K., Tanaka N., Satoh E., Nukada T., Okada S. Determination of strain-specific wall teichoic acid structures in Lactobacillus plantarum reveals diverse alpha-d-glucosyl substitutions and high structural uniformity of the repeating units. Microbiology 2012, 158:2712-2723.
46. Remus D.M., van Kranenburg R., van Swam I.I., Taverne N., Bongers R.S., Wels M., Wells J.M., Bron P.A., Kleerebezem M. Impact of 4 Lactobacillus plantarum capsular polysaccharide clusters on surface glycan composition and host cell signaling. Microb Cell Fact 2012, 11:149.
47. Lebeer S., Verhoeven T.L., Francius G., Schoofs G., Lambrichts I., Dufrene Y., Vanderleyden J., De Keersmaecker S.C. Identification of a gene cluster for the biosynthesis of a long, galactose-rich exopolysaccharide in Lactobacillus rhamnosus GG and functional analysis of the priming glycosyltransferase. Appl Environ Microbiol 2009, 75:3554-3563.
48. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 2008, 72:728-764. (table of contents).
49. Nothaft H., Szymanski C.M. Protein glycosylation in bacteria: sweeter than ever. Nat Rev Microbiol 2010, 8:765-778.
50. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., Molle D., Lortal S., Altermann E., Klaenhammer T.R., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008, 105:19474-19479.
51. Yan F., Cao H., Cover T.L., Whitehead R., Washington M.K., Polk D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132:562-575.
52. Lebeer S., Claes I.J., Balog C.I., Schoofs G., Verhoeven T.L., Nys K., von Ossowski I., de Vos W.M., Tytgat H.L., Agostinis P., et al. The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG. Microb Cell Fact 2012, 11:15.
53. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., Zaat B.A., Yazdanbakhsh M., Wierenga E.A., van Kooyk Y., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115:1260-1267.
54. Fredriksen L., Mathiesen G., Moen A., Bron P.A., Kleerebezem M., Eijsink V.G., Egge-Jacobsen W. The major autolysin Acm2 from Lactobacillus plantarum undergoes cytoplasmic O-glycosylation. J Bacteriol 2012, 194:325-333.
55. Settem R.P., Honma K., Nakajima T., Phansopa C., Roy S., Stafford G.P., Sharma A. A bacterial glycan core linked to surface (S)-layer proteins modulates host immunity through Th17 suppression. Mucosal Immunol 2013, 6:415-426.
56. Rabinovich G.A., van Kooyk Y., Cobb B.A. Glycobiology of immune responses. Ann N Y Acad Sci 2012, 1253:1-15.
57. Bernardo D., Sanchez B., Al-Hassi H.O., Mann E.R., Urdaci M.C., Knight S.C., Margolles A. Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS ONE 2012, 7:e36262.
58. Corcoran B.M., Stanton C., Fitzgerald G., Ross R.P. Life under stress: the probiotic stress response and how it may be manipulated. Curr Pharm Des 2008, 14:1382-1399.
59. Bron P.A., Wels M., Bongers R.S., van Bokhorst-van de Veen H., Wiersma A., Overmars L., Marco M.L., Kleerebezem M. Transcriptomes reveal genetic signatures underlying physiological variations imposed by different fermentation conditions in Lactobacillus plantarum. PLoS ONE 2012, 7:e38720.
60. van Bokhorst-van de Veen H., Lee I.C., Marco M.L., Wels M., Bron P.A., Kleerebezem M. Modulation of Lactobacillus plantarum gastrointestinal robustness by fermentation conditions enables identification of bacterial robustness markers. PLoS ONE 2012, 7:e39053.
61. van Baarlen P., Troost F.J., van Hemert S., van der Meer C., de Vos W.M., de Groot P.J., Hooiveld G.J., Brummer R.J., Kleerebezem M. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A 2009, 106:2371-2376.
62. Lambert J.M., Weinbreck F., Kleerebezem M. In vitro analysis of protection of the enzyme bile salt hydrolase against enteric conditions by whey protein-gum arabic microencapsulation. J Agric Food Chem 2008, 56:8360-8364.
63. van Baarlen P., Troost F., van der Meer C., Hooiveld G., Boekschoten M., Brummer R.J., Kleerebezem M. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4562-4569.
64. Palumbo E., Deghorain M., Cocconcelli P.S., Kleerebezem M., Geyer A., Hartung T., Morath S., Hols P. d-Alanyl ester depletion of teichoic acids in Lactobacillus plantarum results in a major modification of lipoteichoic acid composition and cell wall perforations at the septum mediated by the Acm2 autolysin. J Bacteriol 2006, 188:3709-3715.